SeaStar Medical Holding Corporation - Common Stock (ICU)
0.4199
-0.0031 (-0.73%)
NASDAQ · Last Trade: Jun 27th, 3:40 AM EDT
Detailed Quote
Previous Close
0.4230
Open
0.4200
Bid
0.4050
Ask
0.4100
Day's Range
0.3751 - 0.4443
52 Week Range
0.3054 - 13.85
Volume
6,940,262
Market Cap
-
PE Ratio (TTM)
-
EPS (TTM)
-
Dividend & Yield
N/A (N/A)
1 Month Average Volume
14,374,032
Chart
About SeaStar Medical Holding Corporation - Common Stock (ICU)
SeaStar Medical Holding Corporation is a biotechnology company focused on developing innovative therapies to enhance the treatment of life-threatening kidney conditions. The company is primarily engaged in researching and creating advanced medical devices and technologies designed to improve the care of patients with acute kidney injury and other renal-related disorders. By leveraging its proprietary approach, SeaStar Medical aims to provide solutions that reduce the need for dialysis and improve patient outcomes, ultimately transforming the standard of care in nephrology. Read More
Curious to know what's happening on the US markets in the middle of the day on Wednesday? Join us as we explore the top gainers and losers in today's session.
Stay up-to-date with the latest market trends one hour before the close of the markets on Friday. Explore the top gainers and losers during today's session in our detailed report.
Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top gainers and losers in today's session.
The session on Friday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
DETROIT, MICHIGAN - May 29, 2025 ( NEWMEDIAWIRE ) - SeaStar Medical Holding Corporation (NASDAQ: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, is seeing double-digit growth in sales of QUELIMMUNE, which drove revenues for the company in the first quarter of 2025.
DETROIT, MICHIGAN - May 21, 2025 ( NEWMEDIAWIRE ) - Eric Schlorff, CEO of SeaStar Medical Holding Corp. (NASDAQ: ICU), was recently a guest on Benzinga’s All-Access.
DETROIT, MICHIGAN - May 13, 2025 ( NEWMEDIAWIRE ) - When it comes to approving medical devices, the U.S. Food and Drug Administration can be notoriously slow . To speed up the process, about ten years ago, the FDA launched its Breakthrough Device Designation (BDD) program. It’s designed to encourage speedier development of certain medical devices when there is a reasonable chance of providing a better treatment or diagnosis than the current standard of care. The BDD status is reserved for those diseases that are life-threatening or can cause irreversibly debilitating effects on patients.
DETROIT, MICHIGAN - May 12, 2025 ( NEWMEDIAWIRE ) - Pediatric acute kidney injury (AKI) impacts approximately 4,000 children in the U.S. each year, and the prognosis for these patients is grim. The mortality rate is 50%, they spend twice as long in the ICU, and more than 30% will develop chronic kidney disease following AKI - noted SeaStar Medical in its recent investor presentation. Yet finding effective treatments doesn’t typically receive the same attention as adult AKI or other illnesses caused by infections, injuries and surgeries.
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.
